Brokerages forecast that U.S. Physical Therapy, Inc. (NYSE:USPH) will announce $0.48 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for U.S. Physical Therapy’s earnings, with estimates ranging from $0.47 to $0.48. U.S. Physical Therapy reported earnings of $0.49 per share in the same quarter last year, which suggests a negative year over year growth rate of 2%. The firm is scheduled to announce its next earnings report on Wednesday, June 6th.
On average, analysts expect that U.S. Physical Therapy will report full year earnings of $2.08 per share for the current financial year, with EPS estimates ranging from $2.06 to $2.10. For the next year, analysts expect that the business will report earnings of $2.41 per share, with EPS estimates ranging from $2.35 to $2.45. Zacks Investment Research’s EPS averages are a mean average based on a survey of research firms that that provide coverage for U.S. Physical Therapy.
U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Thursday, November 2nd. The company reported $0.48 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.52 by ($0.04). U.S. Physical Therapy had a net margin of 5.29% and a return on equity of 13.37%. The business had revenue of $103.03 million during the quarter, compared to analyst estimates of $102.69 million.
In other news, CFO Lawrance W. Mcafee sold 5,200 shares of the company’s stock in a transaction dated Wednesday, November 8th. The stock was sold at an average price of $66.37, for a total transaction of $345,124.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Christopher J. Reading sold 15,000 shares of the company’s stock in a transaction dated Wednesday, November 8th. The stock was sold at an average price of $66.52, for a total value of $997,800.00. The disclosure for this sale can be found here. Insiders have sold 23,000 shares of company stock valued at $1,535,652 over the last ninety days. 3.10% of the stock is owned by insiders.
Several hedge funds have recently bought and sold shares of the company. Pinebridge Investments L.P. boosted its position in shares of U.S. Physical Therapy by 1.0% during the second quarter. Pinebridge Investments L.P. now owns 1,650 shares of the company’s stock worth $100,000 after buying an additional 17 shares during the period. Texas Permanent School Fund boosted its position in shares of U.S. Physical Therapy by 0.8% during the second quarter. Texas Permanent School Fund now owns 9,142 shares of the company’s stock worth $552,000 after buying an additional 76 shares during the period. Municipal Employees Retirement System of Michigan raised its holdings in U.S. Physical Therapy by 3.1% during the second quarter. Municipal Employees Retirement System of Michigan now owns 2,950 shares of the company’s stock worth $178,000 after acquiring an additional 90 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. raised its holdings in U.S. Physical Therapy by 3.0% during the second quarter. Los Angeles Capital Management & Equity Research Inc. now owns 6,868 shares of the company’s stock worth $415,000 after acquiring an additional 200 shares in the last quarter. Finally, Thrivent Financial For Lutherans raised its holdings in U.S. Physical Therapy by 5.9% during the second quarter. Thrivent Financial For Lutherans now owns 7,570 shares of the company’s stock worth $457,000 after acquiring an additional 420 shares in the last quarter. 99.75% of the stock is owned by institutional investors.
U.S. Physical Therapy (USPH) traded down $0.45 during trading hours on Friday, reaching $71.50. The company’s stock had a trading volume of 43,412 shares, compared to its average volume of 57,553. U.S. Physical Therapy has a 1 year low of $56.50 and a 1 year high of $78.00. The company has a current ratio of 2.04, a quick ratio of 2.04 and a debt-to-equity ratio of 0.30. The firm has a market capitalization of $905.21, a PE ratio of 34.76, a price-to-earnings-growth ratio of 3.09 and a beta of 1.08.
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 8th. Shareholders of record on Friday, November 17th will be paid a $0.20 dividend. The ex-dividend date of this dividend is Thursday, November 16th. This represents a $0.80 dividend on an annualized basis and a yield of 1.12%. U.S. Physical Therapy’s payout ratio is 48.19%.
TRADEMARK VIOLATION WARNING: This report was first published by Community Financial News and is owned by of Community Financial News. If you are reading this report on another website, it was illegally stolen and reposted in violation of United States and international trademark and copyright laws. The legal version of this report can be read at https://www.com-unik.info/2017/12/04/zacks-analysts-anticipate-u-s-physical-therapy-inc-usph-to-announce-0-48-earnings-per-share.html.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
What are top analysts saying about U.S. Physical Therapy Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for U.S. Physical Therapy Inc. and related companies.